Shandong Wit Dyne Health Income Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020
Operating Revenue	2,355	2,131	2,477	2,330	2,019	1,814
Other Revenue	3.73	3.73	7.57	10.77	8.29	7.31
Revenue	2,359	2,134	2,484	2,341	2,027	1,821
Revenue Growth (YoY)	10.06%	-14.08%	6.11%	15.49%	11.32%	1.17%
Cost of Revenue	418.91	389.59	339.11	502.67	630.37	716.34
Gross Profit	1,940	1,745	2,145	1,838	1,397	1,105
Selling, General & Admin	590.34	504.26	749.35	600.84	525.53	412.03
Research & Development	105.89	101.43	95.59	65.59	80.45	95.89
Other Operating Expenses	55.56	34.21	36.29	39.05	16.21	22.51
Operating Expenses	745.7	640.17	888.83	705.04	619.88	540.6
Operating Income	1,194	1,105	1,256	1,133	776.89	564.09
Interest Expense	-	-	-0.24	-0.22	-	-0.28
Interest & Investment Income	31.27	47.62	42.56	17.95	39.83	27.11
Currency Exchange Gain (Loss)	-0.02	-0.02	0.07	0.05	-0.04	-0
Other Non Operating Income (Expenses)	-0.49	-0.09	2.39	-0.01	5.47	1.86
EBT Excluding Unusual Items	1,225	1,152	1,301	1,151	822.15	592.79
Impairment of Goodwill	-	-	-	-	0.2	-
Gain (Loss) on Sale of Investments	12.12	10.04	14.04	2.07	1.59	9.73
Gain (Loss) on Sale of Assets	-	-	1.39	-	-0.85	-0.08
Asset Writedown	-2.8	-	-	-0.88	-0.13	-2.67
Other Unusual Items	20.27	15.93	8.97	6.87	-1.84	14.46
Pretax Income	1,255	1,178	1,325	1,159	821.12	614.25
Income Tax Expense	173.98	172.19	198.3	161.3	116.82	81.53
Earnings From Continuing Operations	1,081	1,006	1,127	997.89	704.3	532.72
Minority Interest in Earnings	-522.62	-490.44	-541.82	-471.02	-324.04	-241.96
Net Income	558.24	515.59	585.26	526.86	380.26	290.76
Net Income to Common	558.24	515.59	585.26	526.86	380.26	290.76
Net Income Growth	13.95%	-11.90%	11.08%	38.55%	30.78%	42.46%
Shares Outstanding (Basic)	234	234	234	234	235	234
Shares Outstanding (Diluted)	234	234	234	234	235	234
Shares Change (YoY)	-0.03%	0.11%	-0.02%	-0.24%	0.11%	-0.05%
EPS (Basic)	2.38	2.20	2.50	2.25	1.62	1.24
EPS (Diluted)	2.38	2.20	2.50	2.25	1.62	1.24
EPS Growth	13.98%	-12.00%	11.11%	38.89%	30.64%	42.53%
Free Cash Flow	1,263	885.97	1,124	1,107	635.51	633.79
Free Cash Flow Per Share	5.39	3.78	4.80	4.73	2.71	2.70
Dividend Per Share	2.500	2.500	2.000	0.800	0.800	0.350
Dividend Growth	-	25.00%	150.00%	-	128.57%	16.67%
Gross Margin	82.24%	81.75%	86.35%	78.53%	68.90%	60.66%
Operating Margin	50.63%	51.76%	50.57%	48.41%	38.32%	30.98%
Profit Margin	23.66%	24.15%	23.56%	22.50%	18.76%	15.97%
Free Cash Flow Margin	53.53%	41.51%	45.25%	47.27%	31.35%	34.80%
EBITDA	1,267	1,178	1,330	1,202	846.14	629.51
EBITDA Margin	53.72%	55.17%	53.52%	51.33%	41.74%	34.57%
D&A For EBITDA	72.7	72.96	73.3	68.41	69.26	65.41
EBIT	1,194	1,105	1,256	1,133	776.89	564.09
EBIT Margin	50.63%	51.76%	50.57%	48.41%	38.32%	30.98%
Effective Tax Rate	13.87%	14.61%	14.96%	13.91%	14.23%	13.27%
Revenue as Reported	2,359	2,134	2,484	-	-	1,821
Advertising Expenses	-	61.69	91.47	55.27	38.25	40.2

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.